Skip main navigation

New offer! Get 30% off one whole year of Unlimited learning. Subscribe for just £249.99 £174.99. New subscribers only. T&Cs apply

Find out more

Considerations for altering therapy & Summary

Considerations for altering therapy & Summary

Prof. Mary Ferrill demonstrates how to evaluate CPGs with a case study and summarizes this week in this video.

To begin with, we still have some considerations for altering therapy, including greater safety, greater effectiveness, and greater patient convenience.

Furthermore, we are given a case and asked to answer the question: what type of EBM is the citation listed in the case?

Besides, please list the 5 questions a clinician should ask to help confirm or doubt this as the correct CPG.

To make sure you have learnt something from this week, please pause this video, review the previous slides for types, and write down answers on your own.

Finally, we hope you have a better understanding of the strengths and limitations of CPGs, and develop your own approach for evaluating CPGs after completing this lesson.

This is the end of this week. If you have any question or thoughts, please share them below.

This article is from the free online

Evidence-Based Medicine in Clinical Pharmacy Practice

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now